Skip to content
10-Q

Quarterly Report

Miromatrix Medical Inc.

0001558370-23-009369

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 5, 2023 27.24M sh
Shares Diluted Q1 2023 · Mar 31, 2023 22.51M sh
Shares Diluted Q1 2023 · Mar 31, 2022 20.48M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$8.62M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$7.43M
Long Term Debt Q1 2023 · Mar 31, 2023 $386K
Long Term Debt Q1 2023 · Dec 31, 2022 $386K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $13.62M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $5.21M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $44.68M
Stockholders Equity Q1 2023 · Mar 31, 2023 $27.8M
Stockholders Equity Q1 2023 · Dec 31, 2022 $26.11M
Stockholders Equity Q1 2023 · Mar 31, 2022 $47.46M
Stockholders Equity Q1 2023 · Dec 31, 2021 $54.13M
Current Liabilities Q1 2023 · Mar 31, 2023 $3.33M
Current Liabilities Q1 2023 · Dec 31, 2022 $4.95M
Total Liabilities Q1 2023 · Mar 31, 2023 $6.44M
Total Liabilities Q1 2023 · Dec 31, 2022 $8.66M
Current Assets Q1 2023 · Mar 31, 2023 $27.35M
Current Assets Q1 2023 · Dec 31, 2022 $27.31M
Total Assets Q1 2023 · Mar 31, 2023 $34.24M
Total Assets Q1 2023 · Dec 31, 2022 $34.76M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.33
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.35
Eps Basic Q1 2023 · Mar 31, 2023 −$0.33
Eps Basic Q1 2023 · Mar 31, 2022 −$0.35
Sga Expense Q1 2023 · Mar 31, 2023 $2.6M
Sga Expense Q1 2023 · Mar 31, 2022 $2.27M
Rd Expense Q1 2023 · Mar 31, 2023 $4.39M
Rd Expense restated Q1 2023 · Mar 31, 2022 $4.01M
Net Income Q1 2023 · Mar 31, 2023 −$7.48M
Net Income Q1 2023 · Mar 31, 2022 −$7.2M
Operating Income Q1 2023 · Mar 31, 2023 −$8.1M
Operating Income restated Q1 2023 · Mar 31, 2022 −$7.19M
Gross Profit Q1 2023 · Mar 31, 2023 −$117.02K
Gross Profit Q1 2023 · Mar 31, 2022 −$118.23K
Cost Of Revenue Q1 2023 · Mar 31, 2023 $125K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $125K
Revenue Q1 2023 · Mar 31, 2023 $7.98K
Revenue Q1 2023 · Mar 31, 2022 $6.77K